Professor Clare Bryant utilized the AI tool Co-Scientist to identify molecular switches linked to infectious diseases. This approach has accelerated her research timeline from two to three years to potentially six months.
The rise of infectious diseases such as Ebola, HIV, flu, and COVID-19 often stems from pathogens jumping from animals to humans. Understanding the molecular changes that enable these transitions is critical for developing preventive measures.
Professor Clare Bryant at the University of Cambridge is employing Co-Scientist to explore hypotheses about molecular switches involved in severe diseases like sepsis. Initially, she fed the AI tool a summary of a grant proposal, leading to valuable insights and new hypotheses, which she hadn’t previously considered.
After receiving funding, Bryant submitted a complete proposal into Co-Scientist, resulting in prioritization of a previously overlooked protein. This prompted her to generate refined research targets faster than traditional methods, with a potential reduction in research time from two to three years down to six months.
Bryant's lab is now focused on building cell lines with the identified amino acid mutations to test the formulated hypotheses. If successful, this could offer a groundbreaking method for studying infectious diseases and developing therapeutic strategies.
✨ This summary was generated by AI from the outlets' reporting listed below. It is not independently verified and may contain errors — check the original sources. How BrevFeed works →
Professor Clare Bryant utilized the AI tool Co-Scientist to identify molecular switches linked to infectious diseases. This approach has accelerated her research timeline from two to three years to potentially six months.